Process for synthesizing human H2-prorelaxin, human H2-relaxin and fusion proteins thereof
AssigneeHoward Florey Institute of Experimental Physiology and Medicine
InventorsPeter J. Hudson, Hugh D. Niall, Geoffrey W. Tregear
Life of this patent
Estimating the term…
Abstract
Genes and DNA transfer vectors for the expression of human preprorelaxin; sub-units thereof, including genes and transfer vectors for expression of human prorelaxin and the individual A, B and C peptide chains thereof; and equivalents of all such genes. Methods for synthesis of the peptides involving recombinant DNA techniques.
Claims6
A process for synthesizing human H2-prorelaxin comprising A and B peptides separated from each other by a C peptide, comprising incubating a microorganism, transformed by an expression transfer vector comprising a deoxynucleotide sequence coding for said human H2-prorelaxin under conditions suitable for expression of said sequence coding for said human H2-prorelaxin, and purifying said human H2-prorelaxin from a lysate or culture medium of said microorganism.
A process for synthesizing human H2-relaxin comprising A and B peptides, comprising incubating a microorganism, transformed by an expression transfer vector comprising the deoxynucleotide sequence coding for human H2 -relaxin under conditions suitable for expression of said sequence coding for said human H2-relaxin, and purifying human H2-relaxin from a lysate or culture medium of said microorganism.
A process for making a fusion protein having, as its C-terminal sequence, a polypeptide comprising:
- (i) a H2-relaxin A chain selected from the group consisting of A(1-24) to A(5-24), wherein amino acids 1-24 have the following sequence:
- ##STR1## (ii) a H2-relaxin B chain selected from the group consisting of B(-1-32) to B(4-23), wherein amino acids -1-32 have the following sequence:
- ##STR2## (iii) a human H2-prorelaxin C chain having the amino acid sequence as set forth in FIGS. 2A through 2D as arranged in FIG. 2, wherein the C chain amino acid sequence is modified at the junction of the B/C and C/A chains to facilitate cleavage at the B/C and C/A junctions and subsequent excision of the C chain, and as its N-terminal sequence, a portion of a prokaryotic protein, comprising incubating a microorganism transformed by an expression transfer vector comprising an appropriate deoxynucleotide sequence encoding said fusion protein.
A fusion protein having, as its C-terminal sequence, a polypeptide comprising:
- (i) a H2-relaxin A chain selected from the group consisting of A(1-24) to A(5-24), wherein amino acids 1-24 have the following sequence:
- ##STR3## (ii) a H2-relaxin B chain selected from the group consisting of B(-1-32) to B(4-23), wherein amino acids -1-32 have the following sequence:
- ##STR4## (iii) a human H2-prorelaxin C chain having the amino acid sequence as set forth in FIGS. 2A through 2D as arranged in FIG. 2, wherein the C chain amino acid sequence is modified at the junction of the B/C and C/A chains to facilitate cleavage at the B/C and C/A junctions and subsequent excision of the C chain, and as its N-terminal sequence, a portion of a prokaryotic protein.
Dependencies are inferred from the claim text.